KPCB XIII Associates
Latest statistics and disclosures from KPCB XIII Associates's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PGNY, LUNG, MVLA, and represent 100.00% of KPCB XIII Associates's stock portfolio.
- KPCB XIII Associates has $186M in assets under management (AUM), dropping by -17.00%.
- Central Index Key (CIK): 0001500595
Tip: Access up to 7 years of quarterly data
Positions held by KPCB XIII Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for KPCB XIII Associates
KPCB XIII Associates holds 3 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Progyny Common Stock (PGNY) | 93.0 | $173M | 5.1M | 34.02 |
|
|
| Pulmonx Corporation Common Stock (LUNG) | 5.5 | $10M | 995k | 10.33 |
|
|
| Movella Holdings Common Stock (MVLA) | 1.5 | $2.8M | 5.2M | 0.54 |
|
Past Filings by KPCB XIII Associates
SEC 13F filings are viewable for KPCB XIII Associates going back to 2020
- KPCB XIII Associates 2023 Q3 filed Nov. 8, 2023
- KPCB XIII Associates 2023 Q2 filed Aug. 8, 2023
- KPCB XIII Associates 2023 Q1 filed May 12, 2023
- KPCB XIII Associates 2022 Q4 filed Feb. 7, 2023
- KPCB XIII Associates 2021 Q3 filed Oct. 25, 2021
- KPCB XIII Associates 2021 Q2 filed July 28, 2021
- KPCB XIII Associates 2021 Q1 filed May 13, 2021
- KPCB XIII Associates 2020 Q4 filed Feb. 16, 2021